Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Stem Cells | 12 | 2021 | 1346 | 2.630 |
Why?
|
Limbus Corneae | 12 | 2024 | 144 | 1.950 |
Why?
|
Mesenchymal Stem Cells | 18 | 2024 | 1634 | 1.620 |
Why?
|
Melanoma | 21 | 2019 | 5691 | 1.580 |
Why?
|
Epidermolysis Bullosa Dystrophica | 7 | 2024 | 28 | 1.400 |
Why?
|
Epithelium, Corneal | 5 | 2023 | 249 | 0.770 |
Why?
|
Stem Cells | 14 | 2023 | 3521 | 0.700 |
Why?
|
Mesenchymal Stem Cell Transplantation | 5 | 2023 | 498 | 0.660 |
Why?
|
ATP-Binding Cassette Transporters | 4 | 2014 | 563 | 0.610 |
Why?
|
Skin Neoplasms | 10 | 2024 | 5797 | 0.560 |
Why?
|
Neoplastic Cells, Circulating | 5 | 2019 | 938 | 0.540 |
Why?
|
Collagen Type VII | 5 | 2024 | 22 | 0.530 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2010 | 2825 | 0.510 |
Why?
|
Mice, Inbred NOD | 10 | 2021 | 1825 | 0.430 |
Why?
|
Pigmentation | 1 | 2013 | 144 | 0.420 |
Why?
|
Phospholipids | 1 | 2016 | 784 | 0.410 |
Why?
|
Tumor Escape | 3 | 2010 | 370 | 0.410 |
Why?
|
Melanins | 1 | 2013 | 289 | 0.370 |
Why?
|
Amino Acids | 1 | 2016 | 1713 | 0.350 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2024 | 298 | 0.350 |
Why?
|
Drug Resistance, Neoplasm | 10 | 2021 | 5249 | 0.340 |
Why?
|
Mice, SCID | 8 | 2019 | 2626 | 0.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2018 | 8506 | 0.330 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2015 | 3071 | 0.330 |
Why?
|
Immunologic Surveillance | 1 | 2009 | 92 | 0.320 |
Why?
|
Computational Biology | 1 | 2021 | 3502 | 0.320 |
Why?
|
Spheroids, Cellular | 1 | 2010 | 329 | 0.310 |
Why?
|
Estrogen Antagonists | 1 | 2009 | 151 | 0.310 |
Why?
|
Dermis | 3 | 2022 | 202 | 0.310 |
Why?
|
Coculture Techniques | 4 | 2024 | 1339 | 0.300 |
Why?
|
Corneal Diseases | 3 | 2021 | 536 | 0.300 |
Why?
|
Diabetic Foot | 2 | 2022 | 380 | 0.300 |
Why?
|
Cell Proliferation | 11 | 2024 | 10416 | 0.290 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 557 | 0.290 |
Why?
|
Wound Healing | 7 | 2023 | 2783 | 0.280 |
Why?
|
Mice | 33 | 2024 | 81101 | 0.270 |
Why?
|
Animals | 42 | 2024 | 167768 | 0.270 |
Why?
|
Tamoxifen | 2 | 2009 | 963 | 0.260 |
Why?
|
Ultraviolet Rays | 2 | 2022 | 1076 | 0.250 |
Why?
|
Antigen-Presenting Cells | 2 | 2006 | 964 | 0.250 |
Why?
|
Colorectal Neoplasms | 3 | 2021 | 6852 | 0.250 |
Why?
|
Cell Lineage | 3 | 2009 | 2533 | 0.240 |
Why?
|
Neoplasm Transplantation | 5 | 2016 | 2013 | 0.240 |
Why?
|
Lymphocyte Activation | 6 | 2017 | 5490 | 0.240 |
Why?
|
Gene Amplification | 1 | 2009 | 1085 | 0.240 |
Why?
|
Glucose | 1 | 2016 | 4336 | 0.240 |
Why?
|
Melanocytes | 1 | 2008 | 509 | 0.230 |
Why?
|
Cell Culture Techniques | 2 | 2018 | 1664 | 0.230 |
Why?
|
Graft Survival | 2 | 2015 | 3794 | 0.220 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2022 | 730 | 0.220 |
Why?
|
Cell Line, Tumor | 12 | 2020 | 16886 | 0.220 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2009 | 973 | 0.220 |
Why?
|
Dioxygenases | 2 | 2023 | 332 | 0.220 |
Why?
|
Cell Differentiation | 13 | 2024 | 11471 | 0.210 |
Why?
|
Cell Fusion | 1 | 2003 | 293 | 0.210 |
Why?
|
Pterygium | 1 | 2022 | 26 | 0.210 |
Why?
|
Skin | 7 | 2024 | 4464 | 0.210 |
Why?
|
Mice, Inbred BALB C | 4 | 2015 | 6209 | 0.200 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2024 | 3480 | 0.200 |
Why?
|
Transplantation | 1 | 2003 | 218 | 0.190 |
Why?
|
Corneal Neovascularization | 1 | 2023 | 185 | 0.190 |
Why?
|
Stem Cell Transplantation | 4 | 2018 | 1599 | 0.180 |
Why?
|
Humans | 70 | 2024 | 758406 | 0.180 |
Why?
|
Heart Transplantation | 2 | 2015 | 3220 | 0.180 |
Why?
|
Adjuvants, Immunologic | 2 | 2003 | 1038 | 0.180 |
Why?
|
Keratitis | 1 | 2023 | 239 | 0.170 |
Why?
|
Cells, Cultured | 10 | 2024 | 18940 | 0.170 |
Why?
|
Microsatellite Instability | 1 | 2024 | 715 | 0.170 |
Why?
|
T-Lymphocytes | 6 | 2015 | 10171 | 0.170 |
Why?
|
Cell Separation | 3 | 2019 | 1720 | 0.170 |
Why?
|
Microarray Analysis | 2 | 2014 | 746 | 0.170 |
Why?
|
Immunologic Factors | 1 | 2009 | 1585 | 0.170 |
Why?
|
Drug Resistance, Multiple | 2 | 2005 | 253 | 0.160 |
Why?
|
Leg Ulcer | 1 | 2019 | 70 | 0.160 |
Why?
|
Antibodies, Neoplasm | 1 | 2020 | 280 | 0.160 |
Why?
|
Neovascularization, Physiologic | 2 | 2023 | 1332 | 0.160 |
Why?
|
Isoantigens | 1 | 2001 | 552 | 0.160 |
Why?
|
Doxorubicin | 1 | 2005 | 2209 | 0.150 |
Why?
|
Flow Cytometry | 5 | 2023 | 5864 | 0.150 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 3432 | 0.150 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3754 | 0.150 |
Why?
|
Iron Overload | 1 | 2019 | 240 | 0.140 |
Why?
|
Contact Lenses | 1 | 2018 | 138 | 0.140 |
Why?
|
Glycerylphosphorylcholine | 1 | 2016 | 25 | 0.140 |
Why?
|
Neoplasms | 3 | 2010 | 22032 | 0.140 |
Why?
|
Transplantation, Heterologous | 4 | 2023 | 2378 | 0.130 |
Why?
|
Phosphatidylethanolamines | 1 | 2016 | 129 | 0.130 |
Why?
|
Antigens, Neoplasm | 2 | 2017 | 1997 | 0.130 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2796 | 0.130 |
Why?
|
Interferon-alpha | 2 | 2005 | 918 | 0.130 |
Why?
|
Lactates | 1 | 2016 | 404 | 0.130 |
Why?
|
Signal Transduction | 4 | 2015 | 23342 | 0.130 |
Why?
|
Stem Cell Niche | 1 | 2018 | 345 | 0.120 |
Why?
|
Receptors, Interleukin-8A | 1 | 2014 | 46 | 0.120 |
Why?
|
Interleukin-4 | 2 | 2010 | 1130 | 0.120 |
Why?
|
Mice, Inbred C3H | 1 | 2015 | 915 | 0.120 |
Why?
|
Neoplasm Proteins | 2 | 2020 | 3609 | 0.110 |
Why?
|
Polymerase Chain Reaction | 1 | 2023 | 6068 | 0.110 |
Why?
|
Alanine | 1 | 2016 | 603 | 0.110 |
Why?
|
Immunotherapy | 4 | 2021 | 4641 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5649 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3574 | 0.110 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18119 | 0.110 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2009 | 3599 | 0.110 |
Why?
|
RNA, Viral | 1 | 2021 | 2836 | 0.110 |
Why?
|
Mice, Knockout | 5 | 2017 | 14354 | 0.110 |
Why?
|
Mice, Nude | 2 | 2010 | 3602 | 0.100 |
Why?
|
Hair Color | 1 | 2013 | 131 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1090 | 0.100 |
Why?
|
Cell Division | 3 | 2008 | 4458 | 0.100 |
Why?
|
Matrix Metalloproteinases | 1 | 2014 | 392 | 0.100 |
Why?
|
Amino Sugars | 1 | 2011 | 39 | 0.100 |
Why?
|
Optical Phenomena | 1 | 2012 | 105 | 0.100 |
Why?
|
Transfection | 2 | 2014 | 5779 | 0.100 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2016 | 321 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2016 | 3759 | 0.100 |
Why?
|
Psoriasis | 1 | 2019 | 938 | 0.100 |
Why?
|
Organ Specificity | 1 | 2016 | 1955 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1926 | 0.100 |
Why?
|
Graft vs Host Disease | 1 | 2004 | 3024 | 0.090 |
Why?
|
Interleukin-8 | 1 | 2014 | 696 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2003 | 2244 | 0.090 |
Why?
|
Cornea | 3 | 2023 | 1326 | 0.090 |
Why?
|
5-Methylcytosine | 2 | 2023 | 146 | 0.090 |
Why?
|
Galectin 1 | 1 | 2011 | 128 | 0.090 |
Why?
|
Neovascularization, Pathologic | 3 | 2022 | 2638 | 0.090 |
Why?
|
Neoplasm Metastasis | 3 | 2011 | 4901 | 0.090 |
Why?
|
Gene Knockdown Techniques | 2 | 2015 | 1610 | 0.090 |
Why?
|
Intermediate Filament Proteins | 1 | 2011 | 262 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 2 | 2024 | 1826 | 0.090 |
Why?
|
Graft Rejection | 1 | 2003 | 4426 | 0.090 |
Why?
|
Apoptosis | 4 | 2020 | 9468 | 0.090 |
Why?
|
Fluorescence | 1 | 2012 | 749 | 0.090 |
Why?
|
Phenotype | 5 | 2018 | 16534 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2379 | 0.080 |
Why?
|
DNA Methylation | 2 | 2023 | 4373 | 0.080 |
Why?
|
SOXB1 Transcription Factors | 1 | 2011 | 286 | 0.080 |
Why?
|
Neoplasm Invasiveness | 3 | 2018 | 3617 | 0.080 |
Why?
|
Macrophages | 1 | 2024 | 5737 | 0.080 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2009 | 176 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 3 | 2023 | 4485 | 0.080 |
Why?
|
Nevus, Pigmented | 1 | 2011 | 221 | 0.080 |
Why?
|
Epithelial Cells | 4 | 2022 | 3664 | 0.080 |
Why?
|
Interleukin-1beta | 1 | 2014 | 996 | 0.080 |
Why?
|
Melanoma, Experimental | 1 | 2011 | 559 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 2 | 2005 | 3217 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4023 | 0.080 |
Why?
|
Mice, Inbred C57BL | 4 | 2015 | 22003 | 0.070 |
Why?
|
RNA Interference | 1 | 2016 | 2836 | 0.070 |
Why?
|
Gene Expression | 2 | 2014 | 7583 | 0.070 |
Why?
|
K562 Cells | 1 | 2009 | 639 | 0.070 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2011 | 638 | 0.070 |
Why?
|
Rhodamine 123 | 1 | 2006 | 37 | 0.070 |
Why?
|
Quality Control | 2 | 2020 | 825 | 0.070 |
Why?
|
Metabolomics | 1 | 2016 | 1629 | 0.070 |
Why?
|
Pilot Projects | 2 | 2019 | 8553 | 0.070 |
Why?
|
Gene Knockout Techniques | 1 | 2010 | 802 | 0.070 |
Why?
|
Cell Membrane | 1 | 2016 | 3680 | 0.070 |
Why?
|
Immunomodulation | 2 | 2021 | 545 | 0.070 |
Why?
|
Kidney Neoplasms | 2 | 2005 | 4312 | 0.070 |
Why?
|
Myoblasts, Skeletal | 1 | 2006 | 73 | 0.070 |
Why?
|
Fluorouracil | 1 | 2011 | 1631 | 0.070 |
Why?
|
Tissue Array Analysis | 1 | 2008 | 551 | 0.070 |
Why?
|
Jurkat Cells | 2 | 2024 | 735 | 0.070 |
Why?
|
Cell Movement | 1 | 2018 | 5201 | 0.070 |
Why?
|
Tissue Distribution | 2 | 2021 | 2262 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1134 | 0.060 |
Why?
|
Adult Stem Cells | 1 | 2008 | 221 | 0.060 |
Why?
|
Regeneration | 1 | 2014 | 1505 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2011 | 3156 | 0.060 |
Why?
|
Genomics | 1 | 2021 | 5790 | 0.060 |
Why?
|
Glioblastoma | 1 | 2020 | 3480 | 0.060 |
Why?
|
Antineoplastic Agents | 4 | 2016 | 13591 | 0.060 |
Why?
|
Uterine Neoplasms | 1 | 2014 | 1439 | 0.060 |
Why?
|
Placenta | 1 | 2014 | 1702 | 0.060 |
Why?
|
Tumor Cells, Cultured | 3 | 2018 | 6127 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2024 | 127 | 0.060 |
Why?
|
Lutheran Blood-Group System | 1 | 2023 | 3 | 0.060 |
Why?
|
Interleukin Receptor Common gamma Subunit | 2 | 2016 | 85 | 0.060 |
Why?
|
Ischemia | 2 | 2023 | 1863 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 4549 | 0.060 |
Why?
|
Genetic Loci | 1 | 2013 | 2612 | 0.060 |
Why?
|
DNA, Neoplasm | 1 | 2009 | 1745 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2717 | 0.060 |
Why?
|
Female | 19 | 2021 | 390323 | 0.060 |
Why?
|
Genomic Instability | 1 | 2008 | 704 | 0.060 |
Why?
|
Neutrophils | 1 | 2016 | 3765 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2006 | 886 | 0.050 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2006 | 540 | 0.050 |
Why?
|
Polyploidy | 1 | 2003 | 119 | 0.050 |
Why?
|
Kidney | 2 | 2024 | 7016 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 1 | 2006 | 2470 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4406 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2018 | 22029 | 0.050 |
Why?
|
Alleles | 1 | 2013 | 6895 | 0.050 |
Why?
|
Vimentin | 1 | 2022 | 255 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2006 | 841 | 0.050 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2005 | 675 | 0.050 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4809 | 0.050 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2021 | 149 | 0.050 |
Why?
|
Odds Ratio | 1 | 2013 | 9650 | 0.050 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2001 | 516 | 0.040 |
Why?
|
Germany | 1 | 2022 | 868 | 0.040 |
Why?
|
Male | 15 | 2021 | 358747 | 0.040 |
Why?
|
Peptides | 2 | 2017 | 4341 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2047 | 0.040 |
Why?
|
CpG Islands | 1 | 2004 | 1221 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3801 | 0.040 |
Why?
|
Reference Values | 1 | 2006 | 4919 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2006 | 1651 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2017 | 13447 | 0.040 |
Why?
|
Mice, Inbred Strains | 1 | 2021 | 1759 | 0.040 |
Why?
|
Stromal Cells | 1 | 2024 | 1326 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2004 | 727 | 0.040 |
Why?
|
Histone Code | 1 | 2019 | 155 | 0.040 |
Why?
|
Lymphocytes | 1 | 2006 | 2610 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8981 | 0.040 |
Why?
|
Culture Media | 1 | 2020 | 899 | 0.040 |
Why?
|
Mixed Function Oxygenases | 1 | 2019 | 265 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2001 | 583 | 0.040 |
Why?
|
Models, Biological | 2 | 2016 | 9460 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2015 | 7843 | 0.040 |
Why?
|
Inflammation | 3 | 2024 | 10718 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2024 | 12759 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2011 | 9404 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2004 | 1752 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4169 | 0.040 |
Why?
|
Epithelium | 1 | 2022 | 1605 | 0.040 |
Why?
|
Virus Internalization | 1 | 2021 | 494 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 553 | 0.040 |
Why?
|
Cisplatin | 1 | 2024 | 1645 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12075 | 0.040 |
Why?
|
Glycoproteins | 1 | 2005 | 2205 | 0.040 |
Why?
|
beta Catenin | 1 | 2022 | 1043 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1132 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2023 | 1600 | 0.040 |
Why?
|
3T3 Cells | 1 | 2018 | 1084 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 17617 | 0.030 |
Why?
|
DNA-Binding Proteins | 3 | 2023 | 9574 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11070 | 0.030 |
Why?
|
Keratinocytes | 1 | 2019 | 790 | 0.030 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2016 | 105 | 0.030 |
Why?
|
Neutrophil Activation | 1 | 2016 | 181 | 0.030 |
Why?
|
Kinetics | 1 | 2023 | 6371 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2038 | 0.030 |
Why?
|
Levodopa | 1 | 1996 | 217 | 0.030 |
Why?
|
Cell Survival | 1 | 2005 | 5781 | 0.030 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 1 | 2015 | 77 | 0.030 |
Why?
|
Antiparkinson Agents | 1 | 1996 | 183 | 0.030 |
Why?
|
MicroRNAs | 1 | 2011 | 3783 | 0.030 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2015 | 141 | 0.030 |
Why?
|
Antigens, CD | 1 | 2005 | 3997 | 0.030 |
Why?
|
Antigen-Antibody Complex | 1 | 2016 | 513 | 0.030 |
Why?
|
Esophageal Stenosis | 1 | 1996 | 192 | 0.030 |
Why?
|
Etoposide | 1 | 2016 | 630 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2012 | 9273 | 0.030 |
Why?
|
Viral Proteins | 1 | 2021 | 1801 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1793 | 0.030 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2014 | 186 | 0.030 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2015 | 198 | 0.030 |
Why?
|
Trophoblastic Neoplasms | 1 | 2014 | 88 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1351 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2017 | 823 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15773 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 593 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6313 | 0.030 |
Why?
|
Choriocarcinoma | 1 | 2014 | 121 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 2016 | 622 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2004 | 2980 | 0.030 |
Why?
|
Peroxidase | 1 | 2016 | 605 | 0.030 |
Why?
|
Cytokines | 2 | 2018 | 7338 | 0.030 |
Why?
|
Carboplatin | 1 | 2016 | 788 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5779 | 0.030 |
Why?
|
Down-Regulation | 1 | 2019 | 2904 | 0.030 |
Why?
|
Trophoblasts | 1 | 2014 | 224 | 0.030 |
Why?
|
Vasculitis | 1 | 2016 | 522 | 0.020 |
Why?
|
Drug Therapy | 1 | 2015 | 503 | 0.020 |
Why?
|
Homeostasis | 1 | 2023 | 3301 | 0.020 |
Why?
|
Adult | 5 | 2023 | 219935 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3533 | 0.020 |
Why?
|
Hydatidiform Mole | 1 | 2014 | 254 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2413 | 0.020 |
Why?
|
Monocytes | 1 | 2001 | 2570 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11152 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1668 | 0.020 |
Why?
|
Disease Progression | 1 | 2008 | 13468 | 0.020 |
Why?
|
Aged | 5 | 2019 | 168218 | 0.020 |
Why?
|
Acetylglucosamine | 1 | 2011 | 189 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 1996 | 625 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2311 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1900 | 0.020 |
Why?
|
Calcium | 1 | 2023 | 5721 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3816 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6520 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4711 | 0.020 |
Why?
|
Middle Aged | 4 | 2019 | 219568 | 0.020 |
Why?
|
Lasers | 1 | 2012 | 952 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4087 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2001 | 4158 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2011 | 1751 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2019 | 58683 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23679 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 1958 | 0.020 |
Why?
|
Indoles | 1 | 2015 | 1828 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1893 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2017 | 2723 | 0.020 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2006 | 97 | 0.020 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2006 | 161 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2011 | 1174 | 0.020 |
Why?
|
Risk Factors | 1 | 2013 | 73809 | 0.020 |
Why?
|
Phosphorus Isotopes | 1 | 2005 | 124 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2850 | 0.020 |
Why?
|
Sulfonamides | 1 | 2015 | 1973 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2016 | 3099 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54137 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15591 | 0.020 |
Why?
|
Diltiazem | 1 | 2005 | 131 | 0.020 |
Why?
|
Aging | 1 | 2024 | 8650 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3425 | 0.010 |
Why?
|
Child | 2 | 2021 | 79818 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2011 | 1765 | 0.010 |
Why?
|
Models, Animal | 1 | 2011 | 2112 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 11709 | 0.010 |
Why?
|
Hemorrhage | 1 | 2016 | 3400 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 2800 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5816 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12721 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2001 | 9160 | 0.010 |
Why?
|
Vinblastine | 1 | 2005 | 487 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2004 | 294 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2004 | 426 | 0.010 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2004 | 187 | 0.010 |
Why?
|
Lymphoma | 1 | 2011 | 1896 | 0.010 |
Why?
|
CD40 Ligand | 1 | 2004 | 519 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2018 | 64378 | 0.010 |
Why?
|
Parkinson Disease | 1 | 1996 | 2862 | 0.010 |
Why?
|
Phosphates | 1 | 2005 | 771 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2009 | 21017 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 58808 | 0.010 |
Why?
|
Nanoparticles | 1 | 2012 | 1940 | 0.010 |
Why?
|
Pregnancy | 2 | 2014 | 29742 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6493 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2011 | 2821 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8530 | 0.010 |
Why?
|
Fetus | 1 | 2006 | 1859 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42062 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9518 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29557 | 0.010 |
Why?
|
Ligands | 1 | 2004 | 3258 | 0.010 |
Why?
|
United States | 1 | 2022 | 72136 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12094 | 0.010 |
Why?
|
Esophagoscopy | 1 | 1996 | 390 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 87892 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 10748 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2004 | 4429 | 0.010 |
Why?
|
Radiography | 1 | 1996 | 6954 | 0.000 |
Why?
|